Lab No. : KHA/05-09-2021/SR5184394 Lab Add.
: Newtown, Kolkata-700156
Patient Name : SAMAR DAS Ref Dr. : [Link] .
Age : 42 Y 0 M 0 D Collection Date: 05/Sep/2021 10:31AM
Gender :M Report Date : 05/Sep/2021 02:39PM
Test Name Result Unit Bio Ref. Interval Method
SGPT/ALT , GEL SERUM
SGPT/ALT 22 U/L 7-40 U/L Modified IFCC
URIC ACID, BLOOD , GEL SERUM
URIC ACID,BLOOD 4.8 mg/dL 3.5-7.2 mg/dL Uricase/Peroxidase
GLUCOSE, FASTING , BLOOD, NAF PLASMA
GLUCOSE,FASTING 104 mg/dL Impaired Fasting-100-125 . Gluc Oxidase Trinder
Diabetes- >= 126.
Fasting is defined as no caloric
intake for at least 8 hours.
In the absence of unequivocal hyperglycemia, diagnosis requires two abnormal test results from the same sample or in two separate test samples.
Reference :
ADA Standards of Medical Care in Diabetes – 2020. Diabetes Care Volume 43, Supplement 1.
Page 1 of 3
Lab No. : SR5184394 Name : SAMAR DAS Age : 42 Y 0 M 0 D Gender : M
BILIRUBIN (TOTAL, DIRECT, INDIRECT) , GEL SERUM
BILIRUBIN (TOTAL) 0.5 mg/dL 0.3-1.2 mg/dL Vanadate oxidation
BILIRUBIN (DIRECT) 0.1 mg/dL <0.2 mg/dL Vanadate oxidation
BILIRUBIN INDIRECT 0.4 mg/dl 0-0.9 mg/dl Calculated
CREATININE, BLOOD , GEL SERUM 1.31 mg/dL 0.7-1.3 mg/dL Jaffe, alkaline picrate, kinetic
CHOLESTEROL-TOTAL , GEL SERUM
CHOLESTEROL-TOTAL 123 mg/dL Desirable: < 200 mg/dL Enzymatic
Borderline high: 200-239 mg/dL
High: > or =240 mg/dL
Reference:
National Cholesterol Education Program. Executive summary of the third report of The National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation,
and treatment of high blood cholesterol in adults (Adult
Treatment Panel III). JAMA. May 16 2001;285(19):2486-97.
TRIGLYCERIDES, BLOOD , .
TRIGLYCERIDES 103 mg/dL Normal:: < 150, GPO-Trinder
BorderlineHigh::150-199,
High:: 200-499,
VeryHigh::>500
Reference: National Cholesterol Education Program. Executive summary of the third report of The National Cholesterol Education Program (NCEP) Expert Panel on
detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA. May 16 2001;285(19):2486-97.
TSH (THYROID STIMULATING HORMONE) , GEL SERUM
TSH (THYROID STIMULATING HORMONE) 1.713 µIU/mL 0.55-4.78 µIU/mL CLIA
Serum TSH levels exhibit a diurnal variation with the peak occurring during the night and the nadir, which approximates to 50% of
the peak value, occurring between 1000 and 1600 hours.[1,2]
References:
1. Bugalho MJ, Domingues RS, Pinto AC, Garrao A, Catarino AL, Ferreira T, Limbert E and Sobrinho L. Detection of
thyroglobulin mRNA transcripts in peripheral blood of
individuals with and without thyroid glands: evidence for thyroglobulin expression by blood cells. Eur J Endocrinol
2001;145:409-13.
2. Bellantone R, Lombardi CP, Bossola M, Ferrante A,Princi P, Boscherini M et al. Validity of thyroglobulin mRNA assay
in peripheral blood of postoperative thyroid carcinoma patients in predicting tumor recurrence varies according to the
histologic type: results of a prospective study. Cancer 2001;92:2273-9.
BIOLOGICAL REFERENCE INTERVAL: [ONLY FOR PREGNANT MOTHERS]
Trimester specific TSH LEVELS during pregnancy:
FIRST TRIMESTER: 0.10 – 3.00 µ IU/mL
SECOND TRIMESTER: 0.20 -3.50 µ IU/mL
THIRD TRIMESTER : 0.30 -3.50 µ IU/mL
References:
1. Erik K. Alexander, Elizabeth N. Pearce, Gregory A. Brent, Rosalind S. Brown, Herbert Chen, Chrysoula Dosiou,
William A. Grobman, Peter Laurberg, John H. Lazarus, Susan J. Mandel, Robin P. Peeters, and Scott
[Link] 2017.315-389.[Link]
Lab No. : KHA/05-09-2021/SR5184394 Page 2 of 3
Lab No. : SR5184394 Name : SAMAR DAS Age : 42 Y 0 M 0 D Gender : M
2. Kalra S, Agarwal S, Aggarwal R, Ranabir S. Trimester-specific thyroid-stimulating hormone: An indian perspective.
Indian J Endocr Metab 2018;22:1-4.
Lab No. : KHA/05-09-2021/SR5184394 Page 3 of 3